Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Tarsus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Tarsus Pharmaceuticals Inc
Rating: 0.871139
Author: Trendlyne DVM scores

Momentum Trap

about

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

62.46 -2.72 (-4.17%)

26.73% Fall from 52W High

341.6K

XNAS Volume

XNAS 15 May, 2026 3:03 PM (EDT)

Board Meeting

The next board meeting for Tarsus Pharma Inc is on 26 May 2026 for the purpose of Stifel 2026 Virtual Ophthalmology Forum See details

Low Financial Strength

5.6 / 100

Expensive Valuation

13.0 / 100

Technically Neutral

45.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 51%

9 analysts

Tarsus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

26.73% Fall from 52W High

SWOT Analysis

Tarsus Pharma Inc Live Price Chart